Elena S. Martens‐Uzunova

Erasmus MC — Netherlands

Medicine · Health Sciences

23h-index16.6kcitations87works103.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(27), Cancer-related molecular mechanisms research(25), Cancer, Lipids, and Metabolism(23), Extracellular vesicles in disease(20), RNA modifications and cancer(19)

Publications84 total

Analysis of Urinary Extracellular Vesicles
Neuromethods·2026
<i>ZC3H13</i> Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation
Cancer Research·2025
Translon: a single term for translated regions
Nature Methods·2025· 7 citedOpen Access
Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic
Journal of Extracellular Vesicles·2025· 5 citedOpen Access
Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation
Scientific Reports·2024· 20 citedOpen Access
Figure S8 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Supplementary Table 1 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S7 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S5 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S7 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S3 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S9 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S5 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S2 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S9 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Data from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S6 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Supplementary Table 1 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S4 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
Figure S3 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Guido Jenster(24), Martin E. van Royen(11), Alicia Llorente(7), Ross M. Drayton(7), Ishtiaq Rehman(7), Zhongming Zhao(7), Karl H. Pang(7), Saiful Miah(7), Arndt Hartmann(7), Sheila Blizard(7), Martin F. Lavin(7), Helen E. Bryant(7), Freddie C. Hamdy(7), Robert A. Gardiner(7), James W.F. Catto(7), Stefan A.J. Buck(7), Annelies Van Hemelryk(7), Corrina de Ridder(7), Debra Stuurman(7), Sigrun Erkens‐Schulze(7)